ArticleThoracic cancer2024

Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.

Youjin Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.